Table 5.
The comparison of short-term efficacy between primary and metastatic targets under different tracking methods
Primary targets | CR | PR | SD | ORR |
---|---|---|---|---|
Synchrony | 11 (39.29%) | 15 (53.57%) | 2 (7.14%) | 26 (92.86%) |
Xsight spine | 4 (30.77%) | 7 (53.85%) | 2 (15.38%) | 11 (84.62%) |
P-value | X2 = 0.79, P = 0.67 |
Metastatic targets | CR | PR | SD | ORR |
---|---|---|---|---|
Synchrony | 9 (52.94%) | 7 (41.18%) | 1 (5.88%) | 16 (94.12%) |
Xsight spine | 2 (14.29%) | 7 (50.00%) | 5 (35.71%) | 9 (64.29%) |
P-value | X2 = 6.90, P = 0.032 |